The technology aims to prevent youth access while expanding adult market access to FDA-authorized flavored products.Read More
Tags :FDA
The candidate's position on tobacco harm reduction products remains unclear. Read More
The end of 'Chevron deference' doctrine could have ripple effects across the entire nicotine industry in the United States.Read More
The FDA is contesting a lower court ruling favoring two vaping firms' PMTA submissions.Read More
The requirements are expected to help decrease underage tobacco sales. Read More
While FDA menthol market authorizations are rightly seen as a victory, they may be pyrrhic.Read More
While FDA menthol market authorizations are rightly seen as a victory, they may be pyrrhic.Read More
While FDA menthol market authorizations are rightly seen as a victory, they may be pyrrhic.Read More
The requirement will help streamline the reviewing process of ENDS.Read More
The FDA’s first premarket approval of a mentholated vape product reflects poorly on the agency’s authorization process.Read More
